Inflammation Control

KPV + ARA-290 + BPC 157 — multi-target anti-inflammatory and tissue healing research

Three complementary anti-inflammatory mechanisms: KPV blocks NF-κB and pro-inflammatory cytokine production via melanocortin receptors. ARA-290 suppresses TLR4-mediated neuroinflammation via the innate repair receptor. BPC-157 modulates the NO pathway and prostaglandin metabolism for broad anti-inflammatory activity while simultaneously promoting vascular repair. Useful for studying inflammatory resolution across multiple signalling axes.

For research purposes only. Not for human consumption.